Healthcare -
Biotechnology - NASDAQ - US
$ 39.9894
6.12 %
$ 6.35 B
Market Cap
157.2
P/E
TGTX - COST OF REVENUE
Cost of Revenue TGTX - TG Therapeutics, Inc.
38.5 M
LAST VALUE
1105.11%
2 YEAR CAGR
167.31%
5 YEAR CAGR
0.00%
10 YEAR CAGR